Article

Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis Patients

2021-09-23

Abstract excerpt

<h4>Introduction</h4> Maintenance Hemodialysis (HD) patients are at higher risk of both infection and mortality associated with the new coronavirus 2. Immunization through large-scale vaccination is the cornerstone of infection prevention in this population. This study aims to identify risk factors for low response to the BNT-162b2 (Pfizer BioNTech) vaccine in a HD cohort. <h4>Materials and Methods</h4> Observatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 108b9ed4-c1e3-57e7-b689-a530c1a8469e
DOI: 10.1101/2021.09.21.21263568

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis PatientsDOI 10.1101/2021.09.21.21263568Read

Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative StudySemantic proximity Read

Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity Read

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisSemantic proximity Read

Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsSemantic proximity Read

Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity Read

Vaccination and COVID-19 dynamics in hemodialysis patients: a population-based study in FranceSemantic proximity Read

Improved SARS-CoV-2 neutralization of Delta and Omicron variants of concern after fourth vaccination in hemodialysis patientsSemantic proximity Read

Diminishing immune responses against variants of concern in dialysis patients four months after SARS-CoV-2 mRNA vaccinationSemantic proximity Read

Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patientsSemantic proximity Read

Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of break-through infections in hemodialysis patientsSemantic proximity Read

Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective studySemantic proximity Read

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsSemantic proximity Read